Parents' HPV Stories
NCT06704308 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58
Last updated 2026-04-06
Summary
The goal of this clinical trial is to evaluate the feasibility of intervention implementation in two clinics in rural KY, and its preliminary efficacy with regards to increasing vaccine confidence in a sample of vaccine hesitant parents.
Hypothesis: Parents will report increased vaccine confidence scores post-intervention.
Data from this study will provide preliminary data for a larger scale evaluation of the intervention.
Participants will be asked to complete surveys, view a web-based intervention and then visit with their child's healthcare provider.
Conditions
- HPV Vaccination
Interventions
- BEHAVIORAL
-
Web Application
A web application for vaccine-hesitant parents and their teens with brief, 90-second narrative videos and tailored, motivational content
- BEHAVIORAL
-
Provider Elaborated Prompts
A component for providers that suggests elaborated prompts to be used with parents that align with the content of the web application, are tailored to parent concerns, and are motivational in nature
Sponsors & Collaborators
-
Real Prevention, LLC
collaborator INDUSTRY -
Merck Institute for Therapeutic Research
collaborator UNKNOWN -
Anne E Ray
lead OTHER
Principal Investigators
-
Anne E Ray, PhD. · University of Kentucky
-
Aaron Kruse-Diehr, PhD · University of Kentucky
-
Michael Hecht, PhD · Real Prevention, LLC
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-05-31
- Primary Completion
- 2026-11-30
- Completion
- 2026-11-30
Countries
- United States
Study Locations
More Related Trials
-
The STOP-HPV Trial 1: Communication Intervention
NCT03599557 ·Status: COMPLETED ·Phase: NA
-
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
NCT03429413 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects
NCT00426361 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Safety and Immunogenicity of Co-administering HPV Vaccine With Other Vaccines in Healthy Female Subjects
NCT00369824 ·Status: COMPLETED ·Phase: PHASE3
-
Communication Strategies to Increase HPV Vaccination Intention
NCT06784960 ·Status: COMPLETED ·Phase: NA
-
Perception, Awareness, and Acceptance of Human Papillomavirus Disease and Vaccine Among Parents of Boys Aged 9 to 18 Years
NCT01197079 ·Status: COMPLETED
-
HPV Vaccine Confident Families
NCT06002282 ·Status: SUSPENDED ·Phase: NA
-
A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.
NCT02733068 ·Status: COMPLETED ·Phase: PHASE3
-
Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women
NCT00337818 ·Status: COMPLETED ·Phase: PHASE3
-
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
NCT03609320 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness, Safety and Immunogenicity of GSK Biologicals' HPV Vaccine GSK580299 (Cervarix) Administered in Healthy Adolescents
NCT00534638 ·Status: COMPLETED ·Phase: PHASE4
-
Human Papillomavirus Vaccine Safety & Immunogenicity Trial in Healthy Young Adult Women With HPV Vaccine (GSK1674330A)
NCT00478621 ·Status: COMPLETED ·Phase: PHASE1
-
The STOP-HPV Trial 3: Prompts Intervention
NCT03599583 ·Status: UNKNOWN ·Phase: NA
-
A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine
NCT05680454 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Human Papillomavirus (HPV) 16 Vaccine in the Prevention of HPV 16 Infection in 16- to 23-Year-Old Females (V501-005)
NCT00365378 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
NCT00546078 ·Status: COMPLETED ·Phase: PHASE2
-
Improving HPV Vaccination Rates Among Rural and Native American Adolescents
NCT03801603 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects
NCT00578227 ·Status: COMPLETED ·Phase: PHASE3
-
Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age
NCT00423046 ·Status: COMPLETED ·Phase: PHASE3
-
PREVENT HPV -Related Cancers Trial
NCT07217145 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
HPV Educational Intervention to Increase Acceptance and Completion of Free HPV Vaccination Among Underserved Adults
NCT04474821 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
NCT00365716 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)
NCT01984697 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
NCT01461993 ·Status: COMPLETED ·Phase: PHASE2
-
Developing a Self-persuasion Intervention Promoting Adolescent HPV Vaccination: Feasibility Trial
NCT02535845 ·Status: TERMINATED ·Phase: NA